We came across a bullish thesis on Ascendis Pharma A/S on Tip Ranks’ YouTube Channel. In this article, we will summarize the bulls’ thesis on ASND. Ascendis Pharma A/S’s share was trading at $215.05 as of January 13th. ASND’s forward P/E was 48.78, according to Yahoo Finance.
Ascendis Pharma (ASND) is a biopharma company specializing in innovative therapies for rare diseases, leveraging its proprietary Transcon technology platform to create long-acting prodrugs that improve dosing...
